flexin marketing report
TRANSCRIPT
December 31, 2012 Strategic Marketing Report on ‘Flexin’
Submitted To: Mr. Arif Vaseer 1
December 31, 2012 Strategic Marketing Report on ‘Flexin’
INDUSTRY INTRODUCTION
Pharmaceutical industry is one of the most important industries in the world. It is also
considered as one of the most profitable industries having the third most profitable economic
activity after the tourism and the finance industry. It was said that pharmaceutical industry
will expect to gain more than double of accounting to $1.3 trillion by 2014 with an annual
growth rate of 8% annually. In countries namely China, India, Brazil, Mexico, Indonesia,
Turkey and Russia have one fifth of global share in the pharmaceutical industry.
Pharmaceutical industry like any other industries needs to have a strong and unique
marketing strategy in order to succeed or stay in the business. The needs of their customer
changes as the season, the climate, the weather and the preference change. The innovation
and technology as well as organizational change of a certain business that are involved in the
pharmaceutical company changes as the needs, demands, taste and preferences of the world
change. Another factor that can affect the industry is the existence or appearance of new
diseases for example, headache, migraine, the Severe Acute Respiratory Syndrome, as well as
the bird flu. The said businesses need to discover medicine that will help cure or prevent
these diseases to help save the life of the people as well as to gain profit and build their name.
The pharmaceutical industry is one of the industries that are in great need of focus in
development and production as well as supply to help save lives, prevent diseases as well as
to assist in maintaining the quality of life.
Medicines and drugs have a huge contribution to the health of the world. The discovery and
the development as well as the effective use of drugs had helped to improved the quality of
life of many people by helping to reduce the needs for surgical involvement and the span of
time that they will be spending in the hospital and therefore help many people to save money.
The consumption of drugs or medicine of the world is increasing every year due to the fact
that there are still many people in the world that are living an unhealthy life.
In the case of England, their citizens are spending £7 billion every year where in 80% of the
said amount are all spent on branded or patented products than those generics. United States
is considered as the largest market and the site of the most of the research and development in
the field of drug and medicine occupying 48% of share globally while UK is the center of the
world class science that handles the 10% of the global pharmaceutical R&D expenditure and
estimated to support 65% of all R&D related to health in UK.
Submitted To: Mr. Arif Vaseer 2
December 31, 2012 Strategic Marketing Report on ‘Flexin’
ABOUT COMPANY
Abbott Pakistan is a global, broad-based health care company devoted to discovering new
medicines, new technologies and new ways to manage health. Their products span the
continuum of care, from nutritional products and laboratory diagnostics, through medical
devices and pharmaceutical therapies.
With over 70,000 employees worldwide and a global presence in more than 130 countries,
Abbott is committed to improving people's lives by providing cost effective health care
products and services that consistently meet the needs of our customers.
Abbott Pakistan is part of the global healthcare corporation of Abbott Laboratories, Chicago,
USA.
Abbott started operations in Pakistan as a marketing affiliate in 1948; the company has
steadily expanded to comprise a work force of over 1500 employees. Currently two
manufacturing facilities located at Landhi and Korangi in Karachi continue to use innovative
technology to produce top quality pharmaceutical products.
Abbott Pakistan has leadership in the field of Pain Management, Anesthesia, Medical
Nutrition and Anti-Infectives. Their wide range of products is managed and marketed through
three marketing arms.
On June 29, 2005 Abbott Pakistan Achieved Class 'A' accreditation against the Oliver Wight
ABCD Check list. This was an outstanding achievement, which puts Abbott Pakistan
amongst some of the best global companies in terms of operational excellence.
A continuous process of innovation, research and development at Abbott's worldwide
facilities enables Abbott Pakistan to offer effective solutions for various healthcare
challenges, with products and services that are well focused, within the customer's reach and
contribute to improved health care of the people of Pakistan.
Abbott believes that Corporate Social Responsibility is fundamental to earning and deepening
the trust of the people it serves, an integral part of its commitment to improve lives has
contributed to a number of humanitarian causes and supported various institutions in various
fields including health and education.
Submitted To: Mr. Arif Vaseer 3
December 31, 2012 Strategic Marketing Report on ‘Flexin’
PRODUCT
Now a day in adults, tension and other different headaches are the most common problem. It
is observed in people who are usually busy in their work, home and social lives. This will
lead to tension headaches which tend to feel like a band across the forehead which are often
coupled with sensitivity in the muscles at the back of
the head and the neck. Tension headaches are
generally more common in women than men, and it
is estimated that around half of all women suffer
from at least one tension headache every two weeks.
Flexin (Naproxen) is an advanced tablet which is specially formulated to provide instant
cooling relief from the pain of migraine and severe headache at the point of pain and to help
relaxing tense head and neck muscles. The main triggers which help in causing this pain are
due to stress or anxiety about anything which ultimately leads to depression and then
headache. The other triggers can be poor posture of neck and depression.
These headaches last from thirty minutes to seven days which feel like pressing or tightening
around the head which brings on mild to moderate pain which brings in resulting pain on both
sides of the head. Tension headaches can be relieved by avoiding those situations that lead to
tension in the first place by finding out what is stressing and how we can we manage out and
put an end to it.
By keeping in view of the problems and current era stress in the youngsters this product is
also designed in such a way that this can also be used by the people of age group from 12
years and above. According to some studies medicine related to headache and migraine are
not good for those women who are pregnant or breast feed their child. So this product is
modified in a way that it can be used during pregnancy and breast feeding.
Sometimes for everyday stress, that nothing can be about, Flexin offers quick, natural relief
of tension headaches. The active ingredient of Flexin is Neproxen, which is 100% natural.
Flexin works by causing local sensations of coldness, or cutting of pain followed by a
reliving effect. This action of Naproxen is thought to relax local blood vessels and reduce
sensitivity to pain signals.
Submitted To: Mr. Arif Vaseer 4
December 31, 2012 Strategic Marketing Report on ‘Flexin’
Submitted To: Mr. Arif Vaseer 5
December 31, 2012 Strategic Marketing Report on ‘Flexin’
PAKISTAN’S HEALTH SECTOR OVERVIEW
Health is priority area of the Government activities. The high correlation between the
expenditures on health and productivity in developing countries like Pakistan is enough to
emphasize the importance of increasing health services as an aid to growth.
The Government has attached high priority to improving health facilities because of the high
cost of health and its socio-economic consequences. The new health strategy focused on
health sector investment in order to translate
economic success into social benefits. In Pakistan,
the coverage of health facilities has improved over
the years. The existing network of medical services
consists of 906 hospitals, 4,554 dispensaries, 5,290
basic health units (BHU’s), 552 rural health centers
(RHC’s) and the availability of 98,684 hospital beds.
Besides, there are 93,843 doctors, 5,530 dentists and
46,331 nurses in the country.
The Government in recent years has started giving due priority to health planning by
increasing the health allocation and trying out prioritized programmers with special focus on
particular diseases.
Although medical facilities in the country have improved significantly over the years and is
comparable with other countries of the region with similar socio-economic conditions but
there still remains a very large gap between the availability and requirements. The figures
available about the medical facilities clearly indicate the need for a further expansion in
health facilities. The low level of life expectancy (64 Years), high child mortality rate under 5
year age (105/1000) and high population growth rate at 2.2 percent points out to increasing
needs for better health care and preventive services in the country. The above scenario clearly
indicates the need for further expansion in health facilities and more investments in health
sector.
Submitted To: Mr. Arif Vaseer 6
December 31, 2012 Strategic Marketing Report on ‘Flexin’
PAKISTAN’S HEALTH & PHARMACEUTICAL SECTOR (2011)
Growth Rate of Pakistan Pharmaceutical Sector 11.6 %
Share in GDP 1.85 %
Total No. Companies active in the Field 600
Operating Units out of Total 386
Market Leader GlaxoSmithKline (Pak) Ltd.
Total Investment 1.64 Billion US$
Total Volume of Pharmaceutical Market 34.5 Million US Dollar
Health & Pharmaceutical Sector Exports 292,786 Million US Dollar
Total Drugs registered with Ministry of Health 47,000
Source: Drug Control Organization, Ministry of Health, Pharma Bureau of
Information & Statistics Pakistan, and State Bank of Pakistan.
PAKISTAN’S PHARMACEUTICAL SECTOR OVERVIEW
Pakistan’s pharmaceutical market is small and equally split between multinational and
domestic companies. The pharmaceutical market in Pakistan is dominated by locally
manufactured pharmaceuticals, predominantly generic drugs, which meet around 80% of
country’s needs in 2011. Imported retail medicaments account for the remainder of the
market, although manufacturers rely heavily on imported raw materials for production, being
imported from countries like China, India, North America and Switzerland.
Pakistan is a promising country making advancement to different areas of production.
Pharmaceutical market in Pakistan has shown tremendous space in the recent times. Self
sufficiency is the hall mark of pharmaceutical oriented policies. The increasing export of
Pharmaceuticals from Pakistan is speaking for the quality which is being maintained for
manufacturing of Pharmaceuticals. The export market is expanding to almost all the
continents of the world covering almost 40 major countries. Surplus drugs are being exported
Submitted To: Mr. Arif Vaseer 7
December 31, 2012 Strategic Marketing Report on ‘Flexin’
to a large number of countries particularly to the Asian and African regions with an
expanding trade in the newly emerged central Asian States. About a hundred million strong
populations of the Central Asian States, with almost no local manufacture of medicines,
offers an attractive market for pharmaceutical companies located in Pakistan.
Pakistan meets around 80% of its domestic demand of medicines from local production and
20% through imports. The total volume of pharmaceutical market size is US $ 1.64 Billion
approximately. The market for pharmaceuticals in Pakistan has been expanding at a rate of
around 10-15% since last few years.
Pakistan’s large population of more than 150 million people, expanding economy including
health services, individual rise in purchasing power, general awareness regarding use of new
molecules of drugs, etc. provides an ideal environment for investment in this field.
Presently the Pharmaceutical industry in Pakistan is producing all the major pharmaceutical
dosage forms. Similarly, there are some special products e.g. Immunological, anti-cancer
drugs, certain anti-diabetics, antidotes and products manufactured from biotechnology, which
are still being imported, in the finished form. These specific areas provide excellent
opportunities for investment. Only few bulk pharmaceutical raw materials are being
manufactured locally and most of the Pharmaceutical raw materials are being imported in
large quantities from different counters of the world. This Sector also give challenge to
explore and avail the opportunities.
At Present 30 multinational Pharmaceutical units are producing their products in Pakistan.
334 national/ local units are involved in pharmaceutical manufacturing. The Pharmaceutical
manufacture and trade in Pakistan is regulated through the Drug Act 1976, and the rules
framed there under. This is a fairly comprehensive law. Pakistan was the first amongst the
developing countries in the world to have introduced Good Manufacturing Practices as a
mandatory requirement. Registrations are granted by the Central Licensing and Registration
Board.
Source: Ministry of Health & Drugs control Organization & Ministry of Health.
TOP 10 GLOBAL PHARMACEUTICAL INDUSTRY LEADERS
Submitted To: Mr. Arif Vaseer 8
December 31, 2012 Strategic Marketing Report on ‘Flexin’
1. Bristol-Myers Squibb
2. Glaxo SmithKline
3. Johnson & Johnson
4. Sanofi Aventis
5. Pfizer
6. Schering – Plough
7. Abbott Laboratories
8. Millennium Pharmaceuticals
9. Teva Pharmaceutical Industries
10. Daiichi Sankyo
Source: IMS Health, IMS Drug Monitor
According to the data of 2008-09, GlaxoSmithKline (GSK) tops the list of best
pharmaceutical brand in Pakistan with an average of 11.59% market share and a growth rate
of 8.9% annually. Among national companies, Getz Pharmaceuticals tops the list with a
growth rate of whopping 70% for the last 3 years with a market share of 3.76%. Sami
Pharmaceuticals also tops the list with a market share of 2.79%.
Pakistan’s Pharmaceutical market is the 10th largest in the Asia Pacific, behind the Philipines
with market of US$ 2.58 Billion. Annual Per Capita spending on medicine is US$ 10 in
Pakistan, which is far below the regional average of US$ 142.
REGISTRATION OF DRUGS
Submitted To: Mr. Arif Vaseer 9
December 31, 2012 Strategic Marketing Report on ‘Flexin’
Registration of a drug is granted by the Registration Board, set up by the Federal Government
under the Drug Act, 1976. This Board, which comprises 21
experts in the field, before registering a drug, satisfies
itself of its safety, efficacy, quality and economy. The
Board also take into consideration the public interest,
addition, in respect of registration of a drug for local
manufacture, it is ascertained that the manufacturers
possesses matching facilities.
1. Application for Registration – An application
for registration of a drug to be manufactured locally is made in a prescribed Form-
5 under the Drugs (Licensing, Registering and Advertising) Rules, 1976. An
application for registration of a drug to be imported is made in prescribed Form-5
(A) under the said rules.
2. Evaluation of the Application – The respective offices evaluate the application.
It takes 3-6 months to process the applications for branded generics drugs and 6-
12 months in respect of new molecules.
3. Orders of the central Licensing Board - Once the application is complete and
has been evaluated it is placed before the Registration Board for its orders.
4. Separate Application – For every potency / strength of a drug a separate
application is required.
5. Period of License – A registration once granted is valid for a period of 5 years.
6. Renewal of License – A registration is issued for a period of five years at a time,
after which it is renewable on an application. Once an application for renewal has
been made in time, the registration continues to be in force till the decision on the
application.
7. Suspension/Cancellation/ Denial for Renewal of License – A registration may
be suspended or cancelled for renewal denied if the holder of the registration fails
to comply with the conditions of registration.
The Federal government has set up Expert committees including a committee on Biological
and a committee on Veterinary Drugs for furnishing opinion after drug’s evaluation. The
Registration Board also considers their opinions.
Submitted To: Mr. Arif Vaseer 10
December 31, 2012 Strategic Marketing Report on ‘Flexin’
Submitted To: Mr. Arif Vaseer 11
December 31, 2012 Strategic Marketing Report on ‘Flexin’
KEY CUSTOMER MARKETS:
CONSUMER MARKETS:
“The consumer market represents individuals and families purchasing goods and services for
personal consumption. The consumer market excludes business or government purchases, or
other non-personal investments.” The consumer market is segmented into goods and services.
Goods include durables such as cars and furniture, and non-durables such as food, clothing
and gasoline, Services include items such as housing, electricity, phone, cable, Internet,
health care, airlines, trains, buses, restaurants and banks (Banks, M. R, 2000).
Flexin targets both segment of Market because in Product Category, Flexin is a Tangible
thing that one can Touch, Feel and See and in Services it has Dual Effect toward Headache
and Migraine that is relaxing and cooling, so it gives very valuable services to the consumer.
In both ways, Flexin plays a vital role in consumer marketing.
GLOBAL MARKETS:
Trade in primary raw materials and manufactures has been recorded throughout history, with
goods produced in many regions and exchanged in markets around the globe. Global markets
in this context comprise a number of local exchanges, operating in tandem, and influencing
market prices through the generally accepted interaction of supply and demand” (Sasser,
1996).
A company enters into the global market when it goes internationally and involves in foreign
trade and accordingly Flexin has entered in the global market as has already launched in
different America States and European countries and now they have a plan to enter in the
other continents market to compete globally. In Pakistan it is available on big Retailers and
Medial Stores like Metro, Shaheen Chemist, D. Watson, Khattak’s, Medi-Plus, W. Wilson
and many other places.
Submitted To: Mr. Arif Vaseer 12
December 31, 2012 Strategic Marketing Report on ‘Flexin’
ANALYSIS OF CUSTOMER NEEDS AND WANTS
Learning about customer needs and wants is an important part of competitive analysis as
well. A customer priority has become our business priority. In addition the businesses should
take care that they must not limit their study to priorities that are already manifested in the
marketplace. Indeed, new product development and new innovations in service are essential
to business success in any industry.
In the graph below, an estimate of the number of patients of migraine and their percentage in
Pakistan among different Genders is drawn. Patient from 10 years to 30 Years have more
Migraine problem in Pakistan. After the age of 30, the number of patient’s decreases slightly.
In the early ages, Men have more Migraine problem as compared to Women but after 50,
women have more Migraine Problems.
The Percentage of Patients belongs to different age groups and Gender faces two types of
headaches mostly. One is Migraine and the second one is Tension Type Headache. People at
early age suffer less Tension Type Headache as compare to those people who belong to the
age group of 40 to 70 years old. The rate of people suffer from Migraine is more in the people
belong to the age of 50 to 30 Years.
Submitted To: Mr. Arif Vaseer 13
December 31, 2012 Strategic Marketing Report on ‘Flexin’
The graph above shows the Problem of Tension Type Headache and Migraine people suffer
in a Month. The people suffer from TTH and Migraine 5 times or less than 5 times in a month
have a percentage of 4 to 48 Percent respectively. People who suffer TTH and Migraine in
6 – 14 times in a month having percentage of 11 to 25 percent respectively and the people
having TTH and Migraine problem more than 14 % in a month have a number of 85 and 35
Percent respectively.
In the above graph, a complete Industry Analysis of Pharmaceutical Industry of Pakistan as
well as it exhibits the complete picture of Pakistan Health Sector. In the above Graph
percentage of Patients of Migraine and Headache are shown. It shows that Flexin has a huge
market in Pakistan.
Submitted To: Mr. Arif Vaseer 14
December 31, 2012 Strategic Marketing Report on ‘Flexin’
Submitted To: Mr. Arif Vaseer 15
December 31, 2012 Strategic Marketing Report on ‘Flexin’
DEFINING COMPETITORS
The first step is to define your universe of competitors that some businesses may offer
products or services that largely mirror those offered by your own company, while others
may only dispense one or two products & services that compete with your company's
offerings. The business conducting the competitive analysis has to decide whether latter
examples of competition are incidental or whether they present a potential threat to the
business's financial well-being. If we compare it with the pharmaceutical industry we will
find that these companies are Consultants and business experts who also recommend that
small business owners scan the horizon for potential as well as current competitors. The
gumption of entrepreneurs coupled with the 24-hour electronic flows of capital they can
access worldwide means that competitors suddenly turn up out of nowhere and traditional
barriers to entry in any business fall like bricks in an earthquake.
BASIS OF COMPETITION IN PHARMACEUTICAL INDUSTRY
Pharmaceutical industry is considered as one of the highly competitive industry in the world.
The number of the companies that are emerging in the said industry is the most obvious
evidence that shows the growth and improvement as well as the development of the said
industry. It also shows that those businesses are entering in the said field because it offers a
profitable future for their businesses. Because of the growing demand for the medicine as
well as drugs and the growing numbers of pharmaceutical businesses and companies in the
world, the competition in the said industry is also high. That is the reason why there are many
companies that are spending much for their development and enhancement planning as well
as other activities that will help them to innovate and improve.
Like any other industries and businesses, the pharmaceutical industry is facing a massive
amount of new challenges. There are many factors that affect the overall competition in the
said industry and there are many factors that can add to the competitive advantage of one
particular pharmaceutical company in order for them to be one of the biggest players in the
said industry.
Submitted To: Mr. Arif Vaseer 16
December 31, 2012 Strategic Marketing Report on ‘Flexin’
Pricing and other competitive strategies have been altered by the development of information
technology and other related forces. There are many factors that can affect the competition in
the pharmaceutical industry. The first and foremost is the pricing strategy of any
pharmaceutical company. It can affect the supply and demand side of the pharmaceutical
industry. On the side of the demand, drugs are prescribed by the physicians but due to the
lacking of the necessary information about the comparative prices, consumers will attempt to
gather or aggregate decentralized information by getting information from another patient
that have been into that situation or experience or what so called the herd behavior effect
(2006).
On the other side which is the supply side, pricing strategies are convoluted by the fact that a
firm can convey or permit programmed experiences to other firms (2006). The liking has
been for firms in industrial countries to force down their government for a more strengthened
patents regulation in foreign, particularly less developed countries. Domestic manufacturer’s
claim that they can sell abroad at higher prices if patent laws are strengthened (2006). Pricing
strategy is important to the pharmaceutical companies because most of the consumers,
especially those who belong to the lower class C, always settle for the low price of medicine
or drug.
Another important factor is the research and development. This two said aspects are very
important to any company or industry because innovation is considered as one of the key to
have a competitive advantage. Patenting of medication or pharmaceutical products has a great
affect to the competition in the said industry. The research development teams as well as the
laboratories have been part of a wide competition of who will first discover the antidote for a
specific disease or who will first develop and medicine that will handle or prevent specific
dilemma.
Patents have made the prices of a specific medical product to increase because it gives way to
monopoly of the drugs in the market, because it is believe that the price of the pharmaceutical
products will decrease or will be maintained if the competition will be encouraged.
Competition depends on the pricing process of a specific industry; according to (1995)
differential pricing is the result of the increased opportunities for price discrimination or the
result of the presence of quality or cost differences in diverse sections of prescription drug
markets. Therefore the price discrimination and differentiation are driven not just by the
Submitted To: Mr. Arif Vaseer 17
December 31, 2012 Strategic Marketing Report on ‘Flexin’
exposure of a certain segment of the population which can afford it but by the cost, the
product amenities (2006).
Another factor that can affect the overall performance of pharmaceutical businesses is the
presence of the generic drugs. These are the drugs or medicines that are offering the same
effective power of a particular substance or chemical but in a low price. This is the main
competition of the companies that are offering branded medicine most of the consumers are
settling for the cheap but effective medicines (2006).
That is the reason why many pharmaceutical companies more specifically the
GlaxoSmithKline are spending most much in their development and research planning and
supporting their studies and theory in order for them to create a revolutionary medical
product that will cater the needs, demands, preferences and taste of their consumers. The
main reason why pharmaceutical companies are spending millions of dollars for their
research planning and development is because each and every company is candidate for a
marathon for innovation. The first one to get to the finish line will get an ultimate gift of
competitive advantage.
COMPETITOR ANALYSIS
Bruce Sheiman provided an outline of the importance of competitive analysis to the
pharmaceutical industry that is fairly representative. First, it is critical to discover whether a
competitor is trespassing on your proposed pharmaceutical industry or market franchise or it
is whether a competitor renders your company idea which is not required. Secondly
competition helps to define a pharmaceutical industry market position. Every product has
competition if not then it needs competition to stay in market. Third way is that these
companies give you competition which is helpful to compete for making your product as a
bench mark. By studying your competitors, we can learn much about developing our product
its improvements and innovation.
The competitors of Flexin in the market are many offering a number of treatments for
migraine headaches. A list of them along with their special attributes, brand name, company
name and dosages is as following:
Submitted To: Mr. Arif Vaseer 18
December 31, 2012 Strategic Marketing Report on ‘Flexin’
MIGRAINE TREATMENTS
Generic & Class Brand & Company Strength Formulation
s† Usual Dose
ANALGESIC + BARBITURATE
acetaminophen DOLGIC PLUS (Victory Pharma)
750mg Rx tabs Children: not recommended. Adults: 1 tab every 4 hrs; max 5 tabs/day.
butalbital 50mg
caffeine 40mg
acetaminophen ESGIC PLUS (Mikart)
500mg Rx scored tabs; caps
Children: not recommended. Adults: 1 cap or tab every 4 hours as needed.
butalbital 50mg
caffeine 40mg
acetaminophen FIORICET (Watson)
325mg Rx tabs Children: not recommended. Adults: 1–2 tabs or caps every 4 hours as needed; max 6/day.
butalbital 50mg
caffeine 40mg
acetaminophen PHRENILIN (Valeant)
325mg Rx tabs Children: not recommended. Adults: 1–2 tabs every 4 hours; max 6 tabs daily.
butalbital 50mg
ANALGESIC + BARBITURATE + OPIOID
acetaminophen FIORICET w. CODEIN E (Watson)
325mg CIII caps Children: not recommended. Adults: 1–2 tabs or caps every 4 hours as needed; max 6/day.
butalbital 50mg
caffeine 40mg
codeine phosphate
30mg
ANALGESIC + SALICYLATE
acetaminophen BAYER MIGRAINE FORMULA (Bayer Consumer)
250mg OTC
caplets Children: not recommended. Adults: 2 caplets with a glass of water. Max 2 caplets/24 hours.
Aspirin 250mg
caffeine 65mg
Submitted To: Mr. Arif Vaseer 19
December 31, 2012 Strategic Marketing Report on ‘Flexin’
acetaminophen EXCEDRIN MIGRAINE (Novartis Consumer Health)
250mg OTC
tabs Children: not recommended. Adults: Take with full glass of water. ≥18yrs: 2 tabs every 6 hours as needed; max 8 tabs/day for 2 days.
Aspirin 250mg
caffeine 65mg
ANALGESIC + SEDATIVE + SYMPATHOMIMETIC
acetaminophen MIDRIN (Women First Healthcare)
325mg CIV caps Children: not recommended. Adults: Tension: 1–2 caps every 4 hours; max 8 caps/day. Migraine: 2 caps once then 1 cap every 1 hour; max 5 caps/12 hours.
dichloralphenazone
100mg
isometheptene mucate
65mg
ANALGESIC + SYMPATHOMIMETIC
acetaminophen MIGRATEN (Azur Pharma)
325mg Rx caps Children: not recommended. Adults: Tension: 1–2 caps every 4 hours; max 8 caps/day. Migraine: 2 caps at once, then 1 cap every hour until relieved; max 5 caps/12 hours.
caffeine 100mg
isometheptene mucate
65mg
BARBITURATE + SALICYLATE
Aspirin FIORINAL (Watson)
325mg CIII tabs; caps Children: not recommended. Adults: 1–2 tabs or caps every 4 hours as needed; max 6/day.
butalbital 50mg
caffeine 40mg
BARBITURATE + SALICYLATE + OPIOID
Aspirin FIORINAL w. CODEIN 325mg CIII caps Children: not
Submitted To: Mr. Arif Vaseer 20
December 31, 2012 Strategic Marketing Report on ‘Flexin’
E (Watson)
recommended. Adults: 1–2 tabs or caps every 4 hours as needed; max 6/day.
butalbital 50mg
caffeine 40mg
codeine phosphate
30mg
ERGOT ALKALOID
dihydroergotamine mesylate
D.H.E. 45 (Valeant)
1mg/mL Rx IM, IV, or SC inj
Children: not recommended. Adults: 1mL IV at 1 hour intervals; max 2 doses/day. Or, 1mL IM or SC at 1-hour intervals; max 3 doses/day. For all: max 6 doses/week. Do not use chronically.
MIGRANAL** (Valeant)
4mg/mL Rx nasal spray Children: not recommended. Adults: 1 spray in each nostril, repeat 15 minutes later; max 6 sprays/24 hrs and 8 sprays/wk.
ergotamine tartrate
(various) 1mg Rx tabs Children: not recommended. Adults: 2 tablets at onset of attack, then 1 tablet every ½ hour if needed; max 6 tabs/attack, 10 tabs/week.
caffeine 100mg
ergotamine tartrate
(various) 2mg Rx rectal supp Children: not recommended. Adults: 1 supp rectally at onset of attack, then 1 supp after
caffeine 100mg
Submitted To: Mr. Arif Vaseer 21
December 31, 2012 Strategic Marketing Report on ‘Flexin’
NON-STEROIDAL ANTI-INFLAMMATORY (NSAID)
diclofenac potassium
CAMBIA (Nautilus)
50mg Rx Buffered pwd for oral soln
Children: <18yrs: not recommended.Adults: ≥18yrs: mix 1 packet (50mg) with 30–60mL of water only and drink immediately.
ibuprofen ADVIL MIGRAINE (Wyeth Consumer Healthcare)
200mg OTC
liquid-filled caps
Children: <18yrs: not recommended.Adults: ≥18yrs: Usually 400mg once daily.
MOTRIN MIGRAINE PAIN (McNeil Consumer & Specialty)
200mg OTC
caplets Children: <18yrs: not recommended.Adults: ≥18yrs: Usually 200mg–400mg once daily.
SELECTIVE 5-HT1B/1D RECEPTOR AGONIST
almotriptan (malate)
AXERT (Janssen)
6.25mg, 12.5mg
Rx tabs Adults and Children: <12yrs: not recommended. ≥12yrs: 6.25mg or 12.5mg single dose; may repeat once after 2 hours; max 25mg/24hrs. Hepatic or severe renal impairment (CrCl 10–30mL/minute) or concomitant potent CYP3A4 inhibitors (eg,
Submitted To: Mr. Arif Vaseer 22
December 31, 2012 Strategic Marketing Report on ‘Flexin’
ketoconazole): initially 6.25mg once; max 12.5mg/24 hours. The safety of treating an average of more than 4 headaches over 30 days is not established.
eletriptan HBr RELPAX (Pfizer)
20mg, 40mg
Rx tabs Children: <18yrs: not recommended.Adults: ≥18yrs: 20mg or 40mg once. Reevaluate if no response. May repeat once after 2 hours; max 80mg/day. The safety of treating an average of more than 3 headaches in a 30-day period has not been established.
frovatriptan (as succinate)
FROVA (Endo)
2.5mg Rx tabs Children: <18yrs: not recommended.Adults: ≥18yrs: 2.5mg with fluids; may repeat once after 2 hours; max 7.5mg/24 hours. Reevaluate if no response after 1st dose. The safety of treating an average of more than 4 headaches in a 30-day period has not been established.
naratriptan HCl AMERGE (GlaxoSmithKline)
1mg, 2.5mg
Rx tabs Children: <18yrs: not
Submitted To: Mr. Arif Vaseer 23
December 31, 2012 Strategic Marketing Report on ‘Flexin’
recommended.Adults: ≥18yrs: 1mg or 2.5mg with fluids; may repeat once after 4 hours; max 5mg/24 hours. The safety of treating, on average, more than 4 headaches in a 30-day period has not been established. Mild-to-moderate renal or hepatic impairment: consider lower initial dose; max 2.5mg/24 hours.
rizatriptan (as benzoate)
MAXALT (Merck)
5mg, 10mg
Rx tabs Children: <18yrs: not recommended.Adults: ≥18yrs: Initially 5 or 10mg; may repeat after 2 hrs; max 30mg/day. Concomitant propranolol: use 5mg dose; max 3 doses/day. The safety of treating, on average, more than 4 headaches in a 30-day period has not been established.
MAXALT-MLT* (Merck)
5mg, 10mg
Rx ODT
sumatriptan (as succinate)
ALSUMA (Meridian Med Tech)
6mg/0.5mL
Rx soln for SC inj
Children: <18yrs: not recommended.Adults: ≥18yrs: one (6mg) dose SC to the lateral thigh or upper
Submitted To: Mr. Arif Vaseer 24
December 31, 2012 Strategic Marketing Report on ‘Flexin’
arm only. Reevaluate if no response. May repeat after 1 hour; max two (6mg) doses in 24 hours.
IMITREX INJECTION (GlaxoSmithKline)
4mg/0.5mL, 6mg/0.5mL
Rx SC inj Children: <18yrs: not recommended.Adults: ≥18yrs: 6mg SC (may start at lower dose if 6mg not tolerated). Reevaluate if no response. May repeat after 1 hour; max two 6mg doses in 24 hours.
IMITREX NASAL SPRAY (GlaxoSmithKline)
5mg per spray, 20mg per spray
Rx nasal spray Children: <18yrs: not recommended.Adults: ≥18yrs: 5mg, 10mg, or 20mg once. Reevaluate if no response. May repeat once after 2hrs; max 40mg/day. The safety of treating an average of more than 4 headaches in a 30-day period has not been established.
IMITREX TABLETS (GlaxoSmithKline)
25mg, 50mg, 100mg
Rx tabs Children: <18yrs: not recommended.Adults: ≥18yrs: 25–100mg once, swallow whole with fluids as soon as possible after migraine
Submitted To: Mr. Arif Vaseer 25
December 31, 2012 Strategic Marketing Report on ‘Flexin’
onset; may repeat dose at intervals of at least 2hrs, max 200mg/day; or single-dose tablets up to 100mg/day if injection has been used. Hepatic dysfunction: max 50mg/dose. The safety of treating an average of more than 4 headaches in a 30-day period has not been established.
SUMAVEL DOSEPRO (Zogenix)
6mg/0.5mL
Rx soln for SC inj
Children: <18yrs: not recommended.Adults: ≥18yrs: one DosePro (6mg) SC to the abdomen or thigh only. Reevaluate if no response. May repeat after 1 hour; max two DosePro (6mg) doses in 24 hours.
zolmitriptan ZOMIG (Impax)
2.5mg+, 5mg
Rx tabs Children: <18yrs: not recommended.Adults: ≥18yrs: Initially 2.5mg or lower once. If headache returns, may repeat after 2 hrs; max 10mg/day. Reevaluate if no response after
Submitted To: Mr. Arif Vaseer 26
December 31, 2012 Strategic Marketing Report on ‘Flexin’
1st dose. The safety of treating an average of more than 3 headaches in a 30-day period has not been established. Hepatic impairment: use low dose. ZMT: dissolve on tongue and swallow without water.
ZOMIG NASAL SPRAY (Impax)
5mg per spray
Rx nasal spray Children: <18yrs: not recommended.Adults: ≥18yrs: 5mg once. If headache returns, may repeat once after 2 hrs; max 10mg/day. Reevaluate if no response after 1st dose. The safety of treating an average of more than 4 headaches in a 30-day period has not been established. Hepatic impairment: use low dose oral form.
ZOMIG-ZMT* (Impax)
2.5mg, 5mg
Rx ODT Children: <18yrs: not recommended.Adults: ≥18yrs: Initially 2.5mg or lower once. If headache returns, may repeat after
Submitted To: Mr. Arif Vaseer 27
December 31, 2012 Strategic Marketing Report on ‘Flexin’
2 hrs; max 10mg/day. Reevaluate if no response after 1st dose. The safety of treating an average of more than 3 headaches in a 30-day period has not been established. Hepatic impairment: use low dose. ZMT: dissolve on tongue and swallow without water.
SELECTIVE 5-HT1B/1D RECEPTOR AGONIST + NON-STEROIDAL ANTI-INFLAMMATORY (NSAID)
sumatriptan (as succinate)
TREXIMET (GlaxoSmithKline)
85mg Rx tabs Children: not recommended. Adults: Swallow whole. 1 tab once; may repeat once after 2 hours; max 2 tabs/day. The safety of treating an average of more than 5 migraines in a 30-day period has not been established.
naproxen sodium 500mg
NOTES
* = contains phenylalanine ** = contains caffeine + = scored tablets
† tabs = tablets; caps = capsules; inj = injection; ODT = orally disintegrating tablets; soln = solution; supp = suppositories; IM = intramuscular; IV = intravenous; SC = subcutaneous
(Rev. 9/2012)
Submitted To: Mr. Arif Vaseer 28
December 31, 2012 Strategic Marketing Report on ‘Flexin’
SWOT ANALYSIS OF COMPETITOR
Strengths:
Abbott Pakistan has a leadership in the field of Pain Management, Anesthesia, Medical
Nutrition and Anti-infective. Abbott Pakistan has integrated itself horizontally in the market
as it acquired Knoll Pharma in 200. The strategy was applied to gain access to the new
suppliers, distributors, customers, products and creditors. Abbott Pharma also has strong
Research and Development capabilities. Other than these, it has the following strengths:
Good company reputation.
Strong distribution network.
Strong brand positioning.
Have deep roots in the Pharma business.
Excellent professional management team
Weakness:
The weaknesses that Abbott Pakistan faces are:
Comparatively high price.
Lacking of deep rural penetration.
Employee rededication - High Field Force turnover.
Opportunity:
There are many opportunities that are waiting for the competitors that will help them to grow
and expand. Innovation will help the company to retain and expand their current market.
Another factor is the increasing awareness of the world about how important is heath.
Increase per capita income.
High rate of population increase in Pakistan.
Submitted To: Mr. Arif Vaseer 29
December 31, 2012 Strategic Marketing Report on ‘Flexin’
Promotion intensive market.
Increasing healthcare awareness
Threats:
STRENGTHS
Patents
Brand names
Reputation
Knowledgeable and skilled
development team
Efficient technologies, R&
D and laboratories
WEAKNESSES
Comparatively high price.
Lacking of deep rural
penetration.
Employee rededication -
High Field Force turnover
OPPORTUNITIES
Increase per capita income.
High rate of population
increase in Pakistan.
Promotion intensive market.
Increasing healthcare
awareness
THREATS
Generic drugs
Fake medicines
Presence of potential and more
efficient products
The widespread use of herbal
medicine
The threats that the competitor will be facing is the new, potential and more efficient products
in the market including the presence of local companies that offer the same products that is
offering by all the competitors and another factor is the widespread use of herbal medicine.
The most important threat that the whole pharmaceutical industry is facing is the presence of
Submitted To: Mr. Arif Vaseer 30
December 31, 2012 Strategic Marketing Report on ‘Flexin’
fake medicines that can affect not only the image of the manufacturing companies but also
the health of world. Also another threat is the high Inflation Rate.
COMPETITIVE ADVANTAGE:
Superiority gained by a firm when it can provide the same value as its competitors but at a
lower price, or can charge higher prices by providing greater value through differentiation.
Competitive advantage results from matching core competencies to the opportunities (Brady
and Robertson, 2001)
In other words as we understand it, the competitive advantage is an advantage over
competitors gained by offering consumers greater value, either by means of lower prices or
by providing greater benefits and service that
justifies higher prices. The goal of much of business
strategy is to achieve a sustainable competitive
advantage. Flexin has a strong brand name in U.S.A
as with diverse management and when taking this
brand in Pakistan, it keeps its unique effective way
to get relief from the pain.
Michel Porter has identified two basic types of
competitive advantage:
Cost advantage
Differentiation advantage
So in Flexin Naproxen strategy focusing on Cost Advantage and also being the effective
pain relieving agent.
Submitted To: Mr. Arif Vaseer 31
December 31, 2012 Strategic Marketing Report on ‘Flexin’
Submitted To: Mr. Arif Vaseer 32
December 31, 2012 Strategic Marketing Report on ‘Flexin’
DEMOGRAPHICS:
Age:
The total Population of Pakistan is almost
187,342721 approximately. The growth
rate of population is 1.573% per year. The
Age Structure is 35.4% are children’s
belong to 0-14 Years old. 60.4% people
belong to 15 year to 64 years old and the
number of people 65 years old and above
are just 4.2 % of the total Population of
Pakistan. The usage of Flexin is from 5 year old child to 70 years old person. It means we are
targeting almost 92% population of the whole country. So we have a huge market in Pakistan.
Gender:
Up till now, our product is targeting Male and female both Genders belong to age 5 to 70
Years. The ratio of male and female in Pakistan is 48 % and 52% in Pakistan.
Death and Birth Rate:
The Birth rate in Pakistan is 24 Births in 1000 Families per day but the Death Rate in
Pakistan is just 7 people in 1000 Families per day. Almost 60% people suffering from
Migraine and Headache. Degree of Risk in Diseases in Pakistan is very high because of
Unhealthy Food and Water, Vector borne Disease and Animal as well. The health
expenditures are almost 3.0% of our GDP.
Income:
The product targets every customer especially from lower medium Family to Upper Class
Family. It is little bit costly as compare to Tablets but Flexin has no side effects and
Submitted To: Mr. Arif Vaseer 33
December 31, 2012 Strategic Marketing Report on ‘Flexin’
formulated to provide instant cooling relief from the pain of migraine and severe headache at
the point of pain, and to help relax tense head and neck muscles.
Ref: http://www.indexmundi.com/pakistan/demographics_profile.html
SOCIAL CLASSES IN PAKISTAN
In Pakistan these are the some Social Classes are exist:
1) Upper Social Class
2) Middle Social Class
3) Working Social Class
1. Upper Social Class
The upper social class which generally have high level of income and belong to
be most high paying profession and they live in most cleanest place of the country and money
will be no problem for them and their size is 8% of the total society and approximately 3.7
million they have 60% to 65% of money of the country.
They are actually
High status leadership
Big business man
Top management of the company
2. Middle Social Class
Middle Social Classes represents those entire people having
their own well established small businesses, or they work as a Manager or Asst. Manager in
any organization. The children of these society study in Local Universities or in Private
sector institutes. The contribution of these classes population in the society is 35% out of the
total population their population is 53 to 54 million of the total population.
They are actually
They are small to medium size business man.
Middle management
Submitted To: Mr. Arif Vaseer 34
December 31, 2012 Strategic Marketing Report on ‘Flexin’
Low ranking Govt. officer
3. Working Social Class
The populations we count in Working Social
Class are not much more educated they are not in
very good profession their income is low and
they build one two room small houses. In
Pakistan these people faces the electricity, water
and Gas problem as well. The size is 57% out
total population of Pakistan.
They are actually
They are very small size shop owner. Skill, semi skill & unskilled
Low grade Govt. staff ( Peons, Driver)
Poor former
Political worker
The Population targeted for Flexin is basically Upper Social Class and Middle Social Class
and somehow Working Social Class of Pakistan. Because Upper Social Class and Middle
Social Class can get the product easily from the market and as per the Pricing Strategy the
Price of Flexin is little bit high as compared to the all the those product people use for
Headache problem. So it can be said that it targets almost 60% of the total population of
Pakistan.
Ref : http://wiki.answers.com/Q/What_are_the_social_classes_in_Pakistan#ixzz1hKt2H3lN
Submitted To: Mr. Arif Vaseer 35
December 31, 2012 Strategic Marketing Report on ‘Flexin’
Submitted To: Mr. Arif Vaseer 36
December 31, 2012 Strategic Marketing Report on ‘Flexin’
PORTER’S FIVE COMPETITIVE FORCES EVALUATION
RIVALRY AMONG COMPETING FIRMS:
Pharmaceutical industry in Pakistan has gain higher growth in the market form last decade in
Pain Management. It has moved ahead from being developing stage but hasn’t got a perfect
development. However, threat of competitors is still an important factor that govern the
operations of this industry; particularly the rivalry between Pharmaceutical industry of
Pakistan. Every company in the industry is striving to develop a competitive edge and
nationally expand as large as possible. Whereas, worldwide inflation and changes in
customer’s perceptions and attitudes is also a driving force toward increased competitive
rivalry. Competitive rivalry in the case of Flexin so high because people are use to of Tablets
and ordinary Methods of treatment.
THREAT OF NEW ENTRANTS:
Threat of new entrants in Pharmaceutical industry is high. This is because the barrier to enter
this market is quite low because little bit previous experience is required to start doing
business in apparel, customers have low brand preference and loyalty, they mostly get addict
of the product they use often and become habitual of that product. In Pakistani market people
are also Price Conscious so if a customer gets a better option elsewhere and that too, for a
lower price, he can switch to that option. But if we talk about specific Entrants of
Competitors in Migraine Strips that is medium because in this regard we are pioneer and if
we succeed we can drive the other forces. Moreover, the government itself not promotes to
any Pharmaceutical company to setting up of new businesses particularly in Pharmaceutical
industry.
THREAT OF SUBSTITUTE PRODUCTS:
In a Pharmaceutical industry, there is no substitute for Medicine because one has to have a
medicine to get rid of his or her pain but there may be a substitute on the procedure of
processing them as well as in comparison of prices. Pharmaceutical industry also faces threat
Submitted To: Mr. Arif Vaseer 37
December 31, 2012 Strategic Marketing Report on ‘Flexin’
of substitute methods of processing. People, especially in a developing country like Pakistan
as well as literate population of Pakistan can easily get the new ideas of Substitute Product
and aware from the Modern Technology and have vast knowledge of Medicine available in
the Market. On the other hand people in Pakistan can find it comfortable to go and buy the
Product from Drug and Medicine Store nearest market from where they can also by other
necessary house hold items. Hence, if we failed to target to each area then for Flexin the
threat of substitute is very high.
BARGAINING POWER OF CUSTOMERS:
Bargaining power of customers is very high in Pakistan. This is because there many choices
to select from and secondly people are use to
the Tablet already in the market. There are few
medicines in Pakistan and although they
cannot be negotiated upon, but they are use to
that tablets. If talked about competing brands
like Paracetamol or Disperin, a buyer cannot
easily switch to other options because it is
observed in Pakistan that customers are loyal
to their brands in fact we can say that they are
use to that particular brand and it’s not easy to switch on other brand and they feel
comfortable by buying the products they are use to buy from. The purpose of product is
homogenous and the prices may either be uniform or else a buyer has to trade-off with quality
of the product.
BARGAINING POWER OF SUPPLIERS:
Bargaining power of suppliers is neither so low nor so high in Pharmaceutical Industry. This
is because they have to have sold their products in the market. In the case of Flexin, they
have a complete their own Supply Chain Management System. So we have to place the order
and supplier has to deliver the order on time because both of us have same purpose to target
more customers and gain more market share.
Submitted To: Mr. Arif Vaseer 38
December 31, 2012 Strategic Marketing Report on ‘Flexin’
Submitted To: Mr. Arif Vaseer 39
December 31, 2012 Strategic Marketing Report on ‘Flexin’
FLEXIN SUPPLY CHAIN
Flexin’s SCM mission is to configure, coordinate and improve all the sequentially related
activities and set of operations with the idea of satisfying the entire chain of suppliers’
suppliers and customers’ customers by providing right product, at the right time, in the right
quantity and becoming highly recognized by our employees, customers and shareholders and
abiding by Government regulations by adhering to strict ethical and moral standards”.
Ref:http://www.quickmba.com/strategy/value-chain/
Submitted To: Mr. Arif Vaseer 40
December 31, 2012 Strategic Marketing Report on ‘Flexin’
FLEXIN SUPPLY CHAIN STRUCTURE
Submitted To: Mr. Arif Vaseer 41
MASTER SCHEDULER
CAPAPCITY
MASTER SCHEDULER
SUPPLY CHAIN MANAGER
LOCAL/ IMPORTED PURCHASE MANAGER
EXPORTS MANAGER
WAREHOUSE MANAGER
MATERIALS MANAGER
PRODUCTION PLANNER
PRODUCTION PLANNER
December 31, 2012 Strategic Marketing Report on ‘Flexin’
Submitted To: Mr. Arif Vaseer 42
December 31, 2012 Strategic Marketing Report on ‘Flexin’
SWOT ANALYSIS
Environmental factors internal to the firm usually can be classified as strengths (S) or
weaknesses (W), and those external to the firm can be classified as opportunities (O) or
threats (T). Such an analysis of the strategic environment is referred to as a SWOT analysis.
Strengths:
characteristics of the
business, or project
team that give it an
advantage over
others
Weaknesses: are
characteristics that
place the team at a
disadvantage relative
to others
Opportunities:
external chances to improve performance in the environment
Threats: external elements in the environment that could cause trouble for the
business or project
SWOT ANALYSIS OF FLEXIN
Strengths:
These are strength of Flexin. First and most important strength of our product is its
reputation in every country because it’s known at international level. Our product is
affordable as compare to substitute available in existing market. With the usages of
Submitted To: Mr. Arif Vaseer 43
December 31, 2012 Strategic Marketing Report on ‘Flexin’
Flexin it provides instant cooling and patient feel relief from headache. It is use able
for every age of patient mean not for especially adult not for younger not for elders it
is for everyone. It contains natural Naproxen. We will make better supply chain to
make easy accessible. Our product has no side effect and it’s for external usages not
for internal. Patient has no hesitation to use it although he will use it at first time.
provide instant cooling relief for headache
suitable for use by adults
contains Naproxen
Easy pronunciation
Market leader
Good reputation among customers
Affordable as substitute
Known at international level
Favorable access to distribution networks
Easy to import
No side affect
No hesitation for first time user
Easily familiar in customer
Long expiry date
Frequently usages
Proactive Strategy
Weaknesses
Here are some points which are weakness of our product Flexin. Some weakness of
our product will discuss. Our product is not useable the patient who have allergy.
Patient of our country easily not satisfy on its treatment and they accept it with test
sample. Our patient have no much awareness with it they accept it. Our competitor
have big image like Disprin, Paracetamol and Brofan and our patient are typically
thinking and take tablets for headache. Our product is going to import that’s why a
little problem in easily accessible every market. Also problem of distribution channel
accrued. Our competitor have strong image which we have to break then we will
capture the market. Another weakness of our product is strong arrivals.
Submitted To: Mr. Arif Vaseer 44
December 31, 2012 Strategic Marketing Report on ‘Flexin’
Do not use in cases of allergy.
Order take time
Lack of access to every where
Distribution channels problem
Lack of competitive strength
Low Customer Awareness
Strong Rivals
Opportunities:
Here are opportunities for our product for Flexin. We have a large scope for our product.
We apply blue ocean strategy on our product and capture the whole market. We will
target the niche market to attract more and more customer. Customer is globally
influenced by our product. Because of new technology customer satisfy easily and
convince to use it. Before new arrival of technology people are use to our product so new
arrival cannot access the benefit.
Satisfaction of customer
Arrival of new technologies
Capture the market
Removal of international trade barriers
Niche target markets
Global influences
Technology development and innovation
Blue Ocean Strategy
Submitted To: Mr. Arif Vaseer 45
December 31, 2012 Strategic Marketing Report on ‘Flexin’
Threats:
Flexin faces different type of threats like new arrival of product. Customer gives
preference to new technology and new taste of product. Existing substitutes are very
strong and make big image in patient mind so it’s another threat. Our government can
create or increase trade barriers. Political factor is a big threat for our product because our
every leader has its own strategy. If sudden demand increase then we cannot sudden
provide too much supply of product. It development is also threat for our product.
Shifts customer in new arrival
Strong substitute
increased trade barriers
Political effects
Market demand
Environmental effects
IT developments
Legislative effects
Competitors
PEST ANALYSIS OF FLEXIN
Political factors:
Political factors are how and to what degree a government intervenes in the economy.
Specifically, political factors include areas such as tax policy, labor law, environmental
law, trade restrictions, tariffs, and political stability. Political factors may also include goods
and services which the government wants to provide or be provided (merit goods) and those
that the government does not want to be provided (demerit goods). Furthermore, governments
have great influence on the health, education, and infrastructure of a nation.
Economic Factors:
Economic factors include economic growth, interest rates, exchange rates and the inflation
rate. These factors have major impacts on how businesses operate and make decisions. For
Submitted To: Mr. Arif Vaseer 46
December 31, 2012 Strategic Marketing Report on ‘Flexin’
example, interest rates affect a firm's cost of capital and therefore to what extent a business
grows and expands. Exchange rates affect the costs of exporting goods and the supply and
price of imported goods in an economy.
Social Factors:
Social factors include the cultural aspects and include health consciousness, population
growth rate, age distribution, career attitudes and emphasis on safety. Trends in social factors
affect the demand for a company's products and how that company operates.
Technological Factor:
Technological factors include technological aspects such as R&D activity, automation,
technology incentives and the rate of technological change. They can determine barriers to
entry, minimum efficient production level and influence outsourcing decisions. Furthermore,
technological shifts can affect costs, quality, and lead to innovation.
4P’s OF FLEXIN
PRODUCT:
By Product we mean the good and services combination the company
offer to the target customers. Product includes Variety, Quality, Design,
Features and Services. In Flexin the product mean all the Flexin 250 and
500 mg Tablets.
Helps to avoid the side effects that can be associated with taking painkillers orally.
Convenient and portable. The neat and handy packing is
convenient for use whenever a headache creeps up, whether at
work, home or on the move.
Submitted To: Mr. Arif Vaseer 47
December 31, 2012 Strategic Marketing Report on ‘Flexin’
PRICE:
Price is amount of money which customer pays to obtain these products. Prices are adjusted
by Product Value, Usage, Competitor situation and current policies also matter to set the
prices. Price includes List Prices, Discounts, Allowances, Payment Period and Credit Terms.
Flexin 250 mg 2x10 (Pack Size) 110.99 M.R.P
Flexin 500 mg 2x10 (Pack Size) 196.33 M.R.P
PLACE/DISTRIBUTION:
Place include the availability of products. The location where the product is available
approachable
Available at all Medical Stores
PROMOTION:
Promotion means the activities that communicate all the ways to promote the product and
persuade target customers and viewers. The commonly ways of communication are
Advertising, Personal Selling, Sales Promotion and Public Relation.
Submitted To: Mr. Arif Vaseer 48
December 31, 2012 Strategic Marketing Report on ‘Flexin’
Submitted To: Mr. Arif Vaseer 49
December 31, 2012 Strategic Marketing Report on ‘Flexin’
EFFECTIVE MARKETING STRATEGIES AND RECOMMENDATIONS
FLEXIN Marketing Plan: For Flexin, promoting the products in Pakistan is also an issue because the drugs cannot be
promoted to the end users. Drugs are promoted to the doctors and in return these doctors
prescribe those drugs to the patients for the end use. As in other industries, marketing plan for
advertising or promoting products is crucial to pharmaceutical industry too. However, the
marketing strategies (as well as advertising strategies) are different from other businesses
because wrong use of Flexin may negatively affect both the end consumers or the patients
and the health care profession.
Traditional Pharmaceutical Marketing Strategies adopted in Pakistan: The pharmaceutical companies traditionally adopt four major marketing strategies for
promoting their products-
1) Giving free samples to doctors;
2) Providing details of their products through journal articles or opinion leaders;
3) Gifts that hold the company logo or details of one or multiple drugs; and
4) Sponsoring continuing medical education.
Pharmaceutical representatives, also popularly known as medical representatives, are the
major pharmaceutical marketing strategy for marketing drugs directly to the physicians.
Typically, the expense of this sales force of any pharmaceutical company comprises anything
ranging from 15-20% of annual product revenues. However, with changing times and new
developments, the pharmaceutical industry faces some very serious strategic issues.
So in Flexin Marketing Strategies we have to adopt the all these necessary strategies to
promote the product in health sector, doctors and ultimately to the end users of Flexin. For
promotion Sales Staff should be active and efficient so that we can capture the huge market
for our product.
Submitted To: Mr. Arif Vaseer 50
December 31, 2012 Strategic Marketing Report on ‘Flexin’
New Pharmaceutical Marketing Strategies- Why Needed?
While most of the pharmaceutical companies successfully employ a host of marketing
strategies to target various types of customers, the current business and customer trends are
continuously creating new challenges as well as opportunities for increasing profitability. If
we want to improve our Return-On-Investment (ROI), we have to adopt new communication
technologies (digital media) along with their conventional sales force of medical
representatives. We really need to adopt this multi channel marketing strategies for the
following reasons.
1) The concept of blockbuster drugs is that all those Drugs who capture the whole
market and people use to those product, they in fact addicted of that product. So to
capture we have to use new way of communication in the market.
2) As far as other pharmaceutical companies are concerned, they already have sales
force. However, with the use of digital media, having a lower investment cost we can
easily get return on investment.
3) Customer behavior (doctors’ behavior) is rapidly changing. Doctors, who are getting
more and busier with increasing patients, can be hardly seen by the medical
representatives. They are more inclined towards Internet for obtaining relevant
information. It is the time to build their marketing strategies around this digital media.
Website marketing, online marketing, social media, forums, chat rooms and any other
such media is an influential means to present the products and offers through opinion
leaders.
The Right Pharmaceutical Marketing Strategy:
The right marketing strategy for any pharmaceutical company would be to build on proven
strategic marketing principles, along with a focus on changing customer behavior. Use of
digital media through Internet marketing plan is the best marketing strategy that can provide
the basis for a changed business model. However, there should be some planning for using
digital media for marketing too. It should be a multi channel marketing strategy but should
identify the target audience. Every digital media used for all people cannot be called the right
marketing strategy. The focus should be on the high value customer segment for
Submitted To: Mr. Arif Vaseer 51
December 31, 2012 Strategic Marketing Report on ‘Flexin’
pharmaceutical products. To formulate a marketing strategy, it is also crucial to know the
existing markets as well as emerging markets of pharmaceutical drugs.
PROACTIVE STRATEGY
FLEXIN strategy is typically a blend of Proactive Actions on the part of managers to capture
and improve the company market position and financial
performance and as needed reactions to unanticipated
developments and fresh market conditions. The biggest portion of
company’s strategy flows from initiated action and business
approaches that are working well enough to merit continuation and
newly launched managerial initiatives to strengthen the company’s
well overall position and performance. In Flexin strategy the management’s game plan is
market analysis and market situation and its conclusions about how to position the company
in the market place and tackle the task of competing for buyer patronage.
BLUE OCEAN STRATEGY
The Flexin marketing strategy is work as blue ocean strategy. Taking the advantage of blue
ocean strategy, it creates uncontested market space. Flexin is pioneer in field of
pharmaceuticals industries who is effective for Migraine, that’s why it has no direct
competitor. So our products Flexin first create demand in customer then capture the whole
market. It also breaks the value-cost trade off.
Six principle of blue ocean strategy for Flexin:
1) Reconstructs market boundaries
2) Focus on big picture, not the number
3) Reach beyond existing demanding
4) Get the strategic sequence right
5) Overcome key organizational hurdles
6) Build execution into strategy
Submitted To: Mr. Arif Vaseer 52
December 31, 2012 Strategic Marketing Report on ‘Flexin’
We are going to make market across the boundary. In Pakistan we are going to make the
market for our product. We are going there within a strategic group within industry.
According to focus on big picture, not the number there is more four steps to explain it these
are under.
We are initiator in pharmaceutical industry that’s why we have no direct competitor yet now,
although few substitute products already available in the market.
We create six paths for our product Flexin according to blue ocean strategy. We get the
advantage of observe the alternative product and services. We eliminate those changes which
we need and which we have don’t need change them or eliminate them.
We make a strategy canvas by observing inside from the field for Flexin and get feedback o
alternative strategy canvas from customer competitor and non customer. Following this
feedback we built better strategy for future strategy.
We distribute our strategic profile for better and easy comparison. We support our product
Flexin to operational moves and our companies to close the gap of actualize to new strategy.
To explain the reach beyond existing demand we have three tier of non-customer.
First tier is “SOON TO BE” non-customer who is the edge of our market for Flexin.
Second tier is “REFUSING ’’non-customer who consciously chooses against market.
Third tier “UNEXPLORED’ ’non-customer who is in market distant form our
product head.
OPERATIONAL STRATEGIES AND GOALS:
Operations strategy is the total pattern of decisions which shape the long-term capabilities of
any type of operations and their contribution to the overall strategy, through the reconciliation
of market requirements with operations resources.
Operations strategy is concerned with how each part of the business is organized to deliver
the corporate and business-unit level strategic direction. Operational strategy therefore
focuses on issues of resources, processes, people etc. According to the nature of business all
businesses adopt different strategies to achieve the objective. Some common strategies are:
Submitted To: Mr. Arif Vaseer 53
December 31, 2012 Strategic Marketing Report on ‘Flexin’
Functional Strategies:
Functional strategy is the approach a functional area takes to achieve corporate and business
unit objectives and strategies by maximizing resource productivity .It is concerned with
developing and nurturing a distinctive competence to provide a company or business unit
with a competitive advantage.
Total Quality Management (TQM):
Total Quality Management (TQM) is a comprehensive and structured approach to
organizational management that seeks to improve the quality of products and services
through ongoing refinements in response to continuous feedback. It is strictly implemented in
Flexin in order to have greater credibility.
Business Level Strategy:
Business Strategy is a term used in business planning that implies a careful selection and
application of resources to obtain a competitive advantage in anticipation of future events or
trends. It is concerned more with how a business competes successfully in a particular
market. It concerns strategic decisions about choice of products, meeting needs of customers,
gaining advantage over competitors, exploiting or creating new opportunities etc. In this
consideration FLEXIN competitors are those which have a great impact on people so it is
essential to adopt such strategy to break this impact for which they are already working as
they have different ideas in order to compete with its rival.
Pricing Strategy:
One of the four major elements of marketing mix is price. Pricing is an important strategic
issue because it is related to the product positioning. Further more pricing affects other
marketing mix elements such as product features and promotion. No matter what type of
product you sell the price you charge your customers or clients will have a direct effect on the
success of your business.
Submitted To: Mr. Arif Vaseer 54
December 31, 2012 Strategic Marketing Report on ‘Flexin’
Submitted To: Mr. Arif Vaseer 55
December 31, 2012 Strategic Marketing Report on ‘Flexin’
CORE COMPETENCY
Core competencies are those capabilities that are critical to a business achieving competitive
advantage. The starting point for analyzing core competencies is recognizing that competition
between businesses is as much a race for competence mastery as it is for market position and
market power. We can also say it as a unique ability that a company acquires from its
founders or developers that cannot be easily reproduced. Core competencies are what give a
company one or more competitive advantages, in creating and delivering value to its
customers in its chosen field.
In simple words we can say that a core competency is a concept in management theory. In
this view it is a specific factor that a business sees as being central to the way it, or its
employees, works. It fulfills three key criteria:
It is not easy for competitors to imitate.
It can be leveraged widely too many products and markets.
It must contribute to the end consumer's experienced benefits.
A core competency can take in various forms, including subject matter know-how, a reliable
process or a close relationship with customers and suppliers. It may also include product
development or culture, such as employee dedication, best Human Resource Management,
good market coverage etc.
Cluster of extraordinary abilities or related 'excellences' that a firm acquires from its
founders, after consistent striving over the years, and which cannot be easily imitated.”
(Lawton, 1997). “Core competencies are what give firm one or more competitive advantages,
in creating and delivering value to its customers in its chosen field.” (Suh, 2000).Also called
core capabilities or distinctive competencies. See also core rigidities.
When we talk about the core competencies of 4 head, then different competent features come
in this category as wide product line, strong brand recognition, decentralized management,
diverse brand portfolio and financial strength. Considering all these as the core competencies
4 head has confidence to launch and compete in Pakistani market as well.
These are particular strengths relative to other organizations in the industry which provide the
fundamental basis for the provision of added value. It is the collective learning in
Submitted To: Mr. Arif Vaseer 56
December 31, 2012 Strategic Marketing Report on ‘Flexin’
organizations which involve how to coordinate diverse production skills and integrate
multiple streams of technologies. It is communication, an involvement and a deep
commitment to working across organizational boundaries.
Core competencies will lead an organization to its greatest opportunities. Once we define
our core competencies, will let them exploit and they will show how to set your organization
apart from your competition. Identifying and developing an organization’s core competencies
is way to sustain its long-term success and competitive advantage. Also it is an organizations
ability to lead and motivate its employees towards a common goal which will become easier.
BRAND ELEMENTS
What is brand element?
Basically Brand elements facilitate the
process of consumer brain mapping and play
a key role in building brand equity.
Consumers over period of time are able to
identify the brand through brand elements.
The idea is to develop brand elements, which
can properly communicate about brand and
its point of difference from competing
brands. There are various factors, which add to a good brand element. Brand element should
be such that they can have a great recall power. These sort of logo stays in memory for long
time. So the brand element should be such that it can be easily recalled. Another factor is
significance and application, is branding element conveying either of this two for consumers
or not? Significance here means that brand element should be suitable for that given product
category. Consumer should not be left guessing about brand by looking at the element.
Another factor for a good brand element is design and appearance; of course it depends on
product Category Company is operating. For example, Apple products I-pod and Mac, design
and appearance are such; anyone would be attracted towards them. . Examples of common
brand elements include names, logos, symbols, slogans, and packaging. Marketers often
Submitted To: Mr. Arif Vaseer 57
December 31, 2012 Strategic Marketing Report on ‘Flexin’
choose brand elements to build brand equity to enhance consumers' brand awareness or
facilitate their formation of strong, favorable, and unique brand associations.
Name: The name of our product is Flexin
Logo:
Shapes: It’s just a tablet in oval shape
Color: Its packaging have Purple and White color and tablet have white color.
Slogan: Relieves Pain, Restores Smiles
Following are the some elements which is necessary for any product to become a brand.
1. Memorability Most important element of branding is memorability. The
memorability factor of our brand is the name of the product, because
there is a huge brand Abbot in the Name and Flexin is easy to
remember and pronounced.
2. Meaningfulness Second step of branding element is meaningful. Our product must have
some meaning. So our product is very important in this regard that the
Product name gives the meaning of the product and its usage.
3. Likability Likeability means your product must be likeable. Our product will be
very popular in customer and patient of headache. The usage of the
product is so easy and just like a routine work because it’s just a tablet
you have to take at the time of pain with water.
4. Transferability Also transferability of our product is very easy. The size of our product
and according to its packaging it’s very easy to transfer from one place
to another place. Our product is simply a tablet it’s could not damage
Submitted To: Mr. Arif Vaseer 58
December 31, 2012 Strategic Marketing Report on ‘Flexin’
by pressing or damaging its packing. It is portable so that it is so easy
to move across the boundaries. The Distributor will not face any
difficulty to import the product form one county to another.
5. Adoptability Our product is flexible and update by technology. Flexin is just a new
development in pharmaceutical industry and easy solution of headache
problem especially for those people who have Migraine problem. So
those people can use it and it is easily adoptable in our culture.
Actually there is no side effect of Flexin so that people easily accept it
because it’s external usages. In our society mostly people are become
hesitate and in doubt to use such medicine that have Internal use and
may have some side effect as well.
6. Protect ability It’s legally product according to Pakistan rules and regulation because
it has no side effects. People belongs to any age group can use the
product. There is no issue of
Submitted To: Mr. Arif Vaseer 59
December 31, 2012 Strategic Marketing Report on ‘Flexin’
Submitted To: Mr. Arif Vaseer 60
December 31, 2012 Strategic Marketing Report on ‘Flexin’
RISK MANAGEMENT PROCEDURE
In Risk Management Procedure we have to take different precautionary measures against
unpredictable future plans. In this regard we have to do PEST analysis of the economy as
well as conduct the Industry analysis. Porter Five Forces give a good picture of all the factors
that affect the business environment. This necessary for every business so that in any case
business faces any risk, we have enough resources and capabilities so that we will fight
against all those circumstances and Risks elements.
RISK ANALYSISRisk management is the identification, assessment,
and prioritization of risks followed by coordinated
and economical application of resources to
minimize, monitor, and control the probability and
impact of unfortunate events or to maximize the
realization of opportunities. Risks can come from
uncertainty in financial markets, project failures,
legal liabilities, credit risk, accidents, natural causes
and disasters as well as deliberate attacks from an adversary. Methods, definitions and goals
vary widely according to whether the risk management method is in the context of Project
Management, security, engineering, industrial processes, financial portfolios, actuarial
assessments, or public health and safety.
CREATING A RISK MANAGEMENT PLAN
In Flexin, we select appropriate controls or countermeasures to measure each risk. Risk
mitigation needs to be approved by the appropriate level of management. For instance, a risk
concerning the image of the organization should have taken by the owner, who would have
the authority to decide on risks.
The risk management plan should propose applicable and effective security controls for
managing the risks. A good risk management plan should contain a schedule for control
implementation and responsible persons for those actions.
Submitted To: Mr. Arif Vaseer 61
December 31, 2012 Strategic Marketing Report on ‘Flexin’
IMPLEMENTATION
Implementation follows all of the planned methods for mitigating the effect of the risks.
Purchase insurance policies for the risks that have been decided to be transferred to an
insurer, avoid all risks that can be avoided without sacrificing the entity's goals, reduce
others, and retain the rest.
TYPES OF RISK MANAGEMENT
There are several types of risks that might occur when we construct a coffee shop so we have
to calculate and check that risks as well some of the risks are:
Operational risk
Financial risk
Market risk
Technological risk
Schedule flaw
Employee Threats
Supplier Threats
Import Regulations
The launch the Flexin in Pakistani Market and get sustainable advantages we have to
overcome all these Risk. In this regard a complete Risk management procedure should be
implemented and different steps should be taken to avoid all these risks. In launching the
product and making future plan, we should keep in mind all the Risk Factors in the business
at every stage.
Submitted To: Mr. Arif Vaseer 62
December 31, 2012 Strategic Marketing Report on ‘Flexin’
Submitted To: Mr. Arif Vaseer 63
December 31, 2012 Strategic Marketing Report on ‘Flexin’
LIMITATIONS AND OBSTACLES
It need higher start up Cost to Start a Pharmaceutical Business in Pakistan.
There is Lack of technical, manufacturing, marketing, or engineering expertise
can all be a significant obstacle to successful market entry
Flexin basically capture the niche market. It is more difficult to carve out a niche
in a crowded market.
Punjab government not issues a No Objection Certificate (NOC) to the federal
government for Drug Regulatory Authority (DRA), so no policy making at
Federal Level.
No improvement for the betterment of Pharma industry has so far been taken.
Increase in the Tax rate at the time passes by the Govt.
The major challenge which company faces is the total government control on the
prices of all the enlisted products
Import of product which costs a lot of precious foreign exchange
Rapid devaluation of the rupee against the major currencies, due to which the
profit margins are shrinking
Increasing cost of manpower and energy
Low R&D expenditure, which can lead to the suffering of the masses for not
conducting sufficient research on the newly emerging diseases in the Pakistani
environment
Political instability is another major factor which is emerging as the major
challenge to the pharmaceutical industry, because of discontinuation of the
policies
Market access is challenging and operational risks are high.
Last but not the least, the failing law and order situation, due to which most of
companies have suffered in terms of sales and also lack of reach to the customers
in the affected areas.
Submitted To: Mr. Arif Vaseer 64
December 31, 2012 Strategic Marketing Report on ‘Flexin’
BEFORE USING FLEXIN HEADACHE TABLET
The Flexin Naproxen may soften or even melt at high temperatures (e.g. in a car or in the sun
on a hot day), leading to a risk of distortion or spillage. Do not attempt to use Flexin if the
tablet appears to be distorted, softened or fragmented.
Do not use if you are sensitive to Naproxen.
For your safety do not put in the mouth for long duration.
No evidence of associated side-effects has been demonstrated during use in pregnancy
or lactation; however, no safety data for such use is available.
The Naproxen in Flexin may cause hypersensitivity reactions including contact
dermatitis.
For internal use only
Flexin must only be used with water or milk. Stop using Flexin if it feels uncomfortable. If
you experience any other undesirable effects, or if your symptoms persist or worsen, seek
medical advice. If Flexin is accidentally swallowed, seek medical attention, taking the
information leaflet with you. Keep Flexin away from sources of heat or warmth at all times.
Submitted To: Mr. Arif Vaseer 65
December 31, 2012 Strategic Marketing Report on ‘Flexin’
CONCLUSION
Medicines and drugs have a huge contribution to the
health of the world. The discovery and the
development as well as the effective use of drugs
had helped to improved the quality of life of many
people by helping to reduce the needs for surgical
involvement and the span of time that they will be
spending in the hospital and therefore help many people to save money. Pharmaceutical
industry is one of the most important industries in the world. It is also considered as one of
the most profitable industries having the third more profitable economic activity after the
tourism and the finance industry.
Pakistan’s pharmaceutical market is small and equally split between multinational and
domestic companies. The pharmaceutical market in Pakistan is dominated by locally
manufactured pharmaceuticals, predominantly generic drugs, which meet around 90% of
country’s needs in 2011. Imported retail medicaments account for the remainder of the
market, although manufacturers rely heavily on imported raw materials for production.
Health is priority area of the Government activities. The high correlation between the
expenditures on health and productivity in developing countries like Pakistan is enough to
emphasize the importance of increasing health services as an aid to growth. Pakistan meets
around 80% of its domestic demand of medicines from local production and 20% through
imports. The pharmaceutical market size is Rs. 70 Billion (US $ 1.2 Billion) approximately.
The market for pharmaceuticals in Pakistan has been expanding at a rate of around 10-15%
since last few years.
Flexin Naproxen is formulated to provide instant cooling relief from the pain of migraine and
severe headache at the point of pain and to help relaxing tense head and neck muscles. The
main triggers which help in causing this pain are due to stress or anxiety about anything
which ultimately leads to depression and then headache. The other triggers can be poor
posture of neck and depression. By keeping in view of the problems and current era stress in
Submitted To: Mr. Arif Vaseer 66
December 31, 2012 Strategic Marketing Report on ‘Flexin’
the youngsters this product is also designed in such a way that this can also be used by the
people of age group from 12 years and above.
This is product which is much more easy to be used by the patients at the point of swear pain.
Different age groups and Gender faces two types of headaches mostly. One is Migraine and
the second one is Tension Type Headache. People at early age suffer less Tension Type
Headache as compare to those people who belong to the age group of 40 to 70 years old. The
rate of people suffer from Migraine is more in the people belong to the age of 50 to 30 Years.
The first step is to define your universe of competitors that some businesses may offer
products or services that largely mirror those offered by your own company, while others
may only dispense one or two products & services that compete with your company's
offerings. For identifying the competitors of Flexin we will find that this company is having a
lot of competitors these the products are in tablets, sticks and etc. Pharmaceutical industry is
considered as one of the highly competitive industry in the world. In Competitor Analysis we
do the SWOT analysis of Competitors. Flexin strategy we are focusing on Low Cost Strategy
and we have a Low Cost advantage over the rivals.
In Demographic we analysis of different age groups of Pakistan and Social Classes of
Pakistan. We also get the detail analysis of Porter’s Five Forces for Flexin. In Value Chain
activities all the Primary and Secondary activities of Flexin. Because value chain also is
useful in outsourcing decisions. Understanding the linkages between activities can lead to
more optimal make-or-buy decisions that can result in either a cost advantage or a
differentiation advantage.
To analyze the Market SWOT analysis and PEST analysis is the most important thing to get
the detail reviewed of all these strategies. Financial Analysis describes all the key ratios that
are essential to analyze the profitability and value of the product in the possible market. Core
competency and Brand Elements of the product is also described in depth.
This is the complete Marketing Report include all those essential topics that is necessary for
any product launching in the market. In Pakistan Flexin is a huge potential to get the
profitability and grip market share for the product.
Submitted To: Mr. Arif Vaseer 67
December 31, 2012 Strategic Marketing Report on ‘Flexin’
REFERENCES
http://www.badgerhillpharmacy.co.uk/product_catalogue/4_head_strips/index.html
Accessed at: 17 Dec 2012
http://www.dcomoh.gov.pk/
Accessed at: 19 Dec 2012
http://www.espicom.com/prodcat2.nsf/Product_ID_Lookup/00000314?OpenDocument
Accessed at: 21 Dec 2012
http://google.com/images/
Accessed at: 20 Dec 2012
http://www.indexmundi.com/pakistan/demographics_profile.html
Accessed at: 16 Dec 2012
http://www.ppma.org.pk/PPMAIndustry.aspx
Accessed at: 17 Dec 2012
http://www.plosone.org/article/slideshow.action?uri=info:doi/10.1371/journal.pone.0005827
Accessed at: 15 Dec 2012
http://www.medpk.com/pharmceutical_companies.php
Accessed at: 15 Dec 2012
Drug Control Organization, Ministry of Health, Pharma Bureau of Information & Statistics
Accessed at: 21 Dec 2012
Submitted To: Mr. Arif Vaseer 68
December 31, 2012 Strategic Marketing Report on ‘Flexin’
Generic Pharmaceutical Association
http://www.gphaonline.org/about-gpha/about-generics/facts 2007
Accessed at: 19 Dec 2012
IMS Health, IMS Drug Monitor
http://ivythesis.typepad.com/term_paper_topics/2009/09/
glaxosmithklineplc.html#ixzz1hBJ54v
Accessed at: 16 Dec 2012
Pharmaceutical Industry
http://www.pharmaceutical-drug-manufacturers.com/pharmaceutical-industry/
Accessed at: 15 Dec 2012
Ministry of Health & Drugs control Organization & Ministry of Health.
Accessed at: 22 Dec 2012
The Pharmaceutical Market: USA Opportunities and Challenges.
Accessed at: 18 Dec 2012
The Pharmaceutical Market
http://www.vfa.de/en/statistics/pharmaceuticalmarke
Accessed at: 16 Dec 2012
Pakistan Pharmaceuticals and Healthcare Report Q2 2010,
http://www.reportbuyer.com/pharma_healthcare/country_reports_pharmaceutical/
Accessed at: 18 Dec 2012
Population Clock. Population Census Organization. Statistical Division
http://www.statpak.pk/depts/pcO
Accessed at: 19 Dec 2012
http://www.reportbuyer.com/pharma_healthcare/country_reports_pharmaceutical/
pakistan_pharmaceuticals_healthcare_report_q3.html
Accessed at: 15 Dec 2012
http://wiki.answers.com/Q/What_are_the_social_classes_in_Pakistan#ixzz1hKt2H3lN
Submitted To: Mr. Arif Vaseer 69
December 31, 2012 Strategic Marketing Report on ‘Flexin’
Accessed at: 21 Dec 2012
Submitted To: Mr. Arif Vaseer 70